GIPS and USCAP Present:
The Old and The New: A Comprehensive Approach to the GI Tract

This comprehensive approach to the gastrointestinal system is designed to educate general pathologists, junior GI pathologists and pathologists-in-training on problematic areas of common and unusual lesions, the newest guidelines and how they impact the diagnostic process, and practical approaches and tips to avoid diagnostic pitfalls. The structure of this course, divided along the GI anatomic landscape, allows the faculty to emphasize key diagnostic features of inflammatory, infectious and neoplastic pathology as encountered in biopsy and resection specimens. The cases are selected to assist in developing an appropriate differential with emphasis on how to navigate to the correct diagnosis. Supplementary cases and special studies will augment the discussion to present the full morphologic spectrum and show how to incorporate ancillary studies effectively. At the conclusion of the course, participants will be able to develop and work through the differential diagnostic possibilities and render the best possible diagnosis. This is USCAP mentoring at its best!

USCAP Presents:
Hematopathology Tasting Menu: A Sampling of Delightful Diagnostic Challenges

The most recent (2016) WHO classification of hematologic neoplasms delineates specific diagnostic criteria for well-defined neoplastic entities. However, pathologists who diagnose bone marrow biopsies and lymphoid proliferations often face challenges that are not directly addressed by the WHO system or represent reactive conditions that may mimic hematologic malignancies. These include atypical morphologic features, unexpected immunostaining patterns, and discordant genetic features in neoplastic entities. Pathologists often have difficulties applying the WHO criteria if they are not fully concordant with the expected patterns and/or if they are relatively new entities with which pathologists may be unfamiliar. Moreover, there is inherent subjectivity in interpreting morphologic findings and even the results of ancillary testing. The literature contains reports about the intrinsic interobserver variability in making hematopathology diagnoses and pitfalls when applying established criteria. This course aims to bridge the practice gaps between the 'ideal world' WHO classification system and the 'real world' of hematopathology diagnosis by presenting challenging case examples.

These cases will illustrate how to interpret correctly and apply morphologic criteria in diagnosing hematologic neoplasms (including newer entities), how to avoid diagnosing malignancy in benign mimics, and how appropriately to integrate the results of ancillary testing with the morphology, particularly when there are discordant or unexpected results. We will provide participants with guidelines on how practically to approach such cases and avoid misdiagnosis, thereby improving their performance in daily practice. The target audience is general pathologists who diagnose bone marrow and lymphoid lesions, practicing hematopathologists and hematopathology fellows.

USCAP Presents:
Gynecologic Pathology
Navigating Histologic Mimics and Other Diagnostic Pitfalls

USCAP Presents:
A Contemporary Approach and Update on the Classification, Grading, Staging and Reporting of GU Tumors

Classification, grading, staging and reporting of GU tumors continue to evolve with the discovery of pathogenic mechanisms and the advent of novel diagnostic tools and therapies. It is imperative for practicing pathologists to keep pace with the important changes in GU tumor pathology in order to produce pathology diagnoses and reports that meet contemporary patient management needs. Examples requiring educational focus are the significant error rate and inter-observer variability in the diagnosis of cribriform carcinoma and intraductal carcinoma of prostate; under-recognition and under-reporting of bladder cancer variants; misclassification of testicular germ cell tumors correlated with drastic revision of WHO 2016 classification; modifications in prostate grading correlative with newly described morphologic changes, new outcome data and adjustment to the modified Gleason grading system; changes in GU tumor staging following publication of the 8th edition of the AJCC Staging guidelines; requisite refinements in cancer reporting to eliminate significant variation, error, and missing relevant elements. This course is a pragmatic exercise in mentoring for advanced learning taught by international experts who reflect USCAP’s gold standard.

USCAP Presents:
Modern Surgical Pathology Through the Expert Eyes of APSS-USCAP: THIRD EDITION

USCAP Presents:
Crash Course in Gastrointestinal, Liver and Pancreaticobiliary Pathology: An Emphasis on Current Guidelines and WHO Updates

Based on cumulative experience from subspecialty-based GI practices, this faculty ensemble has identified pathologic entities and concepts in GI, liver and pancreatic pathology that continue to pose diagnostic challenges on a daily basis. Such challenges relate directly to interpreting limited biopsy samples, generating succinct differential diagnoses (particularly for inflammatory conditions, medical liver injury, non-adenocarcinoma neoplasia of pancreas, and non-GIST mesenchymal tumors), the impact of genetics on diagnosis and classification, constantly changing disease classifications and the fluidity of practice guidelines in the context of emerging evidence-based data. This course is designed to provide systematic algorithms for assessing malabsorption disorders, gastritis, colitides, neoplasms, pancreatic inflammatory and neoplastic diseases, and medical liver biopsies that can be implemented in daily practice.

Case discussions will facilitate understanding of basic and recent concepts in terminology, prognostic features, and basic pathobiology for practicing pathologists, enhanced by current management guidelines relevant to Barrett esophagus, IBD-related dysplasia, appendiceal mucinous lesions, pancreatic inflammatory diseases and neoplasms, hepatic inflammatory diseases and neoplasms, and mesenchymal tumors.
You can expect a highly engaging mentoring experience that will improve your performance and practice while learning in a unique destination location orchestrated by USCAP to achieve optimal satisfaction.